AKKARAJU SRINIVAS 4

What Happened

• Akkaraju Srinivas, a director of vTv Therapeutics, was granted a derivative equity award for 6,000 shares on 2026-06-26. The award is reported at $35.08 per share, for a total reported value of $210,480. This is a grant/award (not an open-market purchase or sale).

Key Details

• Transaction date and price: 2026-06-26; 6,000 shares at $35.08 each; total $210,480.
• Transaction type: Award/grant (derivative), reported on Form 4 filed 2026-06-29.
• Vesting note: The award vests on the earlier of June 26, 2027 and the date of the 2027 annual meeting of shareholders, subject to continued board service.
• Shares owned after transaction: Not specified in the information provided.
• Filing timeliness: Form 4 filed 2026-06-29; appears to be a timely filing (no late-filing flag indicated).

Context

• This was a compensation-related award to a director rather than a cash purchase; such grants are common for board members and are tied to continued service via vesting conditions. Because it is a derivative award with vesting, it does not represent an immediate market purchase and should not be interpreted as a direct buy/sell signal.